Larisma, Rosalie C.
HRN: 29-06-72 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
CEFTRIAXONE 1G (VIAL)
05/30/2026
06/05/2026
IV
2g
OD
HAP, Intubated
Checking Initial Appropriateness
05/30/2026
MUPIROCIN 2%, 15G (TUBE)
05/30/2026
06/05/2026
TOPICAL
2%
BID
Ulcer
Checking Initial Appropriateness
05/31/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/31/2026
06/07/2026
IV
4.5
Q6
CAP HR
Checking Initial Appropriateness
06/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2026
06/08/2026
IVTT
900mg
Q8H
CELLULITIS
Checking Initial Appropriateness
06/01/2026
CEFTRIAXONE 1G (VIAL)
06/01/2026
06/08/2026
IV
2g
OD
HAP, Cellulitis
Checking Initial Appropriateness